Correlation Between Tscan Therapeutics and MGIC Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and MGIC Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and MGIC Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and MGIC Investment Corp, you can compare the effects of market volatilities on Tscan Therapeutics and MGIC Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of MGIC Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and MGIC Investment.

Diversification Opportunities for Tscan Therapeutics and MGIC Investment

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Tscan and MGIC is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and MGIC Investment Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MGIC Investment Corp and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with MGIC Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MGIC Investment Corp has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and MGIC Investment go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and MGIC Investment

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the MGIC Investment. In addition to that, Tscan Therapeutics is 2.41 times more volatile than MGIC Investment Corp. It trades about -0.24 of its total potential returns per unit of risk. MGIC Investment Corp is currently generating about -0.02 per unit of volatility. If you would invest  2,527  in MGIC Investment Corp on August 24, 2024 and sell it today you would lose (30.00) from holding MGIC Investment Corp or give up 1.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  MGIC Investment Corp

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
MGIC Investment Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in MGIC Investment Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, MGIC Investment is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Tscan Therapeutics and MGIC Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and MGIC Investment

The main advantage of trading using opposite Tscan Therapeutics and MGIC Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, MGIC Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGIC Investment will offset losses from the drop in MGIC Investment's long position.
The idea behind Tscan Therapeutics and MGIC Investment Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine